BMO Capital analyst Alex Arfaei said they do not believe Bristol-Myers Squibb's (NYSE: BMY) call alleviated the market's increased concerns ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE